These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5016047)

  • 1. Parenchyma weight changes in hepatic cirrhosis. A morphometric study and disscussion of the method.
    Ludwig J; Elveback LR
    Lab Invest; 1972 Mar; 26(3):338-43. PubMed ID: 5016047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver cirrhosis in autopsy material within 48 years. II. Causes of death, liver cell carcinoma, weights of liver and spleen (author's transl)].
    Schubert GE; Bethke-Bedürftig BA; Bujnoch AW; Diem A
    Z Gastroenterol; 1982 Apr; 20(4):221-7. PubMed ID: 7080573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histometrical studies of liver parenchym in two cirrhotic livers (author's transl)].
    Kirchner R; Kalbfleisch H; Hort W
    Leber Magen Darm; 1978 Apr; 8(2):74-7. PubMed ID: 634016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Certain problems of clinical course and morphological changes in the liver in hepatic coma].
    Gordeladze AS; Valenkevich LN; Iakhontove OI
    Klin Med (Mosk); 1976 Feb; 54(2):62-6. PubMed ID: 1271722
    [No Abstract]   [Full Text] [Related]  

  • 5. Obscure hepatomegaly. A clinico-pathological study.
    el-Mehairy MM; Attia O; Nassar I; el-Tarabeeshy NM; Nabih AE
    J Trop Med Hyg; 1969 Oct; 72(10):241-6. PubMed ID: 5360518
    [No Abstract]   [Full Text] [Related]  

  • 6. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
    Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe jaundice due to acute liver cirrhosis].
    Opolon P; Hecht Y; Theodoropoulos G; Hadchouel P; Grynblat A; Caroli J
    Rev Med Chir Mal Foie; 1969; 44(6):251-90. PubMed ID: 5405047
    [No Abstract]   [Full Text] [Related]  

  • 9. The Budd-Chiari syndrome. Report of eight cases.
    Szöör J; Nagy G; Szakáll S
    Acta Med Acad Sci Hung; 1971; 28(2):127-38. PubMed ID: 5148329
    [No Abstract]   [Full Text] [Related]  

  • 10. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 12. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals.
    Herrero JI; Bilbao JI; Diaz ML; Alegre F; Inarrairaegui M; Pardo F; Quiroga J
    Liver Transpl; 2009 Jan; 15(1):111-4. PubMed ID: 19109845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and laboratory findings in the patients with alcoholic steatosis and liver steatofibrosis].
    Knezević S; Kallai L; Gjurasin M
    Lijec Vjesn; 1968; 90(10):929-41. PubMed ID: 5195768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of ascites in cirrhosis of the liver].
    Del Solar V; Lobo G; Varela N; Lehmann C
    Rev Med Chil; 1965 Sep; 93(9):549-56. PubMed ID: 5888085
    [No Abstract]   [Full Text] [Related]  

  • 16. [Optimization of therapy in patients with hepatic cirrhosis and encephalopathy].
    Ivanov AG; Trusov VV
    Klin Med (Mosk); 2008; 86(6):62-6. PubMed ID: 18720715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coexistence of various diseases and the analysis of the causes of death in patients with liver cirrhosis].
    Marlicz K; Szymański Z; Wierzbicka-Paczos E; Tarnowska M; Kordowska M; Kotańska K
    Przegl Lek; 1984; 41(10):617-20. PubMed ID: 6336252
    [No Abstract]   [Full Text] [Related]  

  • 18. Early detection of hepatic encephalopathy by recording visual evoked potential (VEP).
    Zamir D; Storch S; Kovach I; Storch R; Zamir C
    Rocz Akad Med Bialymst; 2002; 47():186-93. PubMed ID: 12533959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An epidemiological survey of subclinical hepatic encephalopathy].
    Zeng Z; Li YY; Nie YQ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):680-2. PubMed ID: 14636446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.